Project Grant R01MH140004
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital $854,029 under the Mental Health Research Grants program (CFDA 93.242) effective September 1, 2025 through August 31, 2030. This project grant supports the development and evaluation of a multimodality adaptive intervention designed to reduce suicide risk among individuals in the critical three-month period following inpatient psychiatric hospitalization. The research leverages a...
- Federal Grant Award Summary This $921,386 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) funds innovative measurement methodology research conducted by RTI International from September 2025 through August 2027. The project addresses critical limitations in existing youth social media (SM) use research by developing and implementing a large language-based computer vision model to automatically analyze screenomics...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital $183,118 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2025, for a four-year project extending through August 31, 2029. Dr. Tubbs will develop and validate clinical phenotyping algorithms that integrate genomic data with electronic health record (EHR) information to advance precision psychiatry. The project addresses three major gaps limiting genomic...
- Federal Grant Award Summary The National Institute of Mental Health awarded a $1.46 million Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Massachusetts General Hospital effective September 15, 2025, through September 14, 2027. The award supports research on "Effect of Network-Based Real Time Neurofeedback Augmentation of Mindfulness Practice on Recurrent Negative Thinking in Adolescents at Risk for Serious Mental Illness." MGH will develop and...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded McLean Hospital Corporation a $193,320 Project Grant effective February 18, 2026, through January 31, 2031, under the Mental Health Research Grants program (CFDA 93.242). This K23 mentored career development award supports research investigating online social networking (OSN) mechanisms related to suicidal thoughts and behaviors (STBS) in adolescents. The research deliverables include establishing objective,...
- Federal Grant Award Summary Massachusetts General Hospital's Research Management Division received a $129,290 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) on August 22, 2025. The award supports a two-year research initiative (through July 31, 2027) examining the relationship between genetic variation and developmental trajectories across autism spectrum disorder (ASD) and schizophrenia (SCZ). The research...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $197,400 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective August 15, 2025, with a completion date of July 31, 2030. The award funds the development and testing of a mobile application (mCBT-AR) designed to deliver cognitive-behavioral therapy for avoidant/restrictive food intake disorder (ARFID), a severe eating disorder affecting...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $412,500 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) beginning September 1, 2025, and concluding August 31, 2027. The award supports the development of a Copy Number Variant (CNV) Discovery Pipeline for Integrated Genome-Exome Sequencing—a computational and analytical infrastructure designed to identify and characterize CNVs (genomic deletions...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a $2.69 million Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective September 1, 2025, through May 31, 2030. This research initiative utilizes advanced brain ultrasound imaging technologies—including high-resolution microvascular imaging (MVI), shear-wave elastography, and quantitative texture analysis (radiomics)—to identify early neurodevelopmental...
- Federal Project Grant Award Summary Miresource, Inc. received a $627,600 project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on September 12, 2025, with completion targeted for March 14, 2026. The project, conducted in partnership with the nonprofit Child Mind Institute (CMI), delivers an integrated digital mental health monitoring platform designed to improve longitudinal patient tracking and enable...
The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital $839,023 under the Mental Health Research Grants program (CFDA 93.242) on April 1, 2026, for research extending through December 31, 2030. This R01 Project Grant supports the development and validation of computer vision techniques to enhance suicide risk detection in emergency department settings. The research builds upon prior R21 exploratory findings and aims to create automated analysis systems that can assess physical tissue damage markers—particularly scars and markings from self-injury—to predict prospective suicide attempt risk among emergency department patients. The project will evaluate whether computer vision-derived signals from standardized skin images provide predictive utility beyond traditional self-reported measures of prior self-injury severity and existing electronic health record-based suicide risk algorithms currently deployed at Mass General Brigham. The research directly addresses the critical public health need of identifying high-risk suicide cases among youth and young adults, for whom suicide represents the second leading cause of death. By leveraging objective imaging analysis rather than relying solely on patient self-reporting, the study seeks to improve clinician decision-making regarding appropriate levels of psychiatric care. The research team will further evaluate model performance across racial and ethnic minority populations to mitigate bias in the developed algorithms. This work represents a novel application of artificial intelligence in clinical psychiatry, translating computer vision technology from exploratory development into a validated clinical tool for emergency care settings.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $839.0k | 3/6/26 |